The need for MRI before breast-conserving surgery

Le‐Petross, Huong T.; Stafford, R. Jason

doi:10.1007/s12609-009-0014-4

Cited by 4 publications

(3 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It has been suggested that MRI could detect unsuspected breast cancers that aren't apparent during mammographic and ultrasound [17][18][19][20][21][22][23][24][25][26][27]. However, the value of preoperative MRI in newly diagnosed breast cancer remains controversial [8,[28][29][30][31][32][33].…”

Section: Discussionmentioning

confidence: 99%

“…It has been well established that MRI detects unsuspected sites of cancer, for example, in the ipsilateral breast in 16% of women. It also identifies occult cancer in the contralateral breast, for example, in 3% to 5% of women with newly diagnosed breast cancer [7,8]. These studies have also shown that most of these lesions will be malignant.…”

Section: Introductionmentioning

confidence: 94%

See 1 more Smart Citation

A Meta-analysis of the Association Between Preoperative Magnetic Resonance Imaging and Surgical Outcomes in Newly Diagnosed Breast Cancer

Xie

Wei

et al. 2021

Arch Med Sci

View full text Add to dashboard Cite

IntroductionThe use of preoperative Magnetic Resonance Imaging (MRI) in newly diagnosed breast cancer has been increasing. However, the value of MRI applied to the women with newly diagnosed breast cancer remains controversial. Therefore, this study focused on the association between preoperative MRI and surgical outcomes, which include mastectom y rate, breast conservation rate, and re-excision rate.Material and methodsA systematic literature search was performed by the Wan fang, VIP (Chinese biomedical databases), PubMed, Cochrane Library, Embase, and Vip databases. The keywords were "breast cancer", "magnetic resonance imaging", "mastectomy rate", "re-excision rate", and "breast conservation rate." A random-effects model was used to estimate the proportion of women with various outcomes in the MRI group, versus a non-MRI group. The odds ratio (OR) for each surgical outcome were calculated.Results4 RCTs (Randomized Controlled Trial) met the eligibility criteria that included a total of 2312 patients with breast cancer. The analysis results of the MRI group versus the non-MRI group were as follows: Mastectomy rate of 15% versus 10%, OR 2.01, 95% CI 0.79-5.11, P=0.14; Breast conservation rate 84% versus 89%, OR 0.58, 95% CI 0.29-1.17, P=0.13; Re-excision rate 17% versus 19%, OR 0.76, 95% CI 0.37-1.54, P=0.45.ConclusionsThere was no significant association between preoperative MRI and surgical outcomes. This study suggested that the use of preoperative MRI should be selective. The results showed that the application of preoperative MRI didn’t improve the prognosis of breast cancer patients. More randomized trials are needed for further study due to limited randomized trials.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 94%

A Meta-analysis of the Association Between Preoperative Magnetic Resonance Imaging and Surgical Outcomes in Newly Diagnosed Breast Cancer

Xie

Wei

et al. 2021

Arch Med Sci

View full text Add to dashboard Cite

show abstract

“…MR-mammography is an imaging modalitythat has recently gained a specific role in selected cases for clinically staging newly diagnosed breast cancer patients. [7] Its wider role in women with moderate risk is still controversial as established data supporting its use in such patients is lacking. [8] A total of 60% of the polled oncologists were of the opinion that MR-Mammogram is an indispensible imaging tool and should be recommendedpre-operatively in all patients before undergoing BCS [ Table 1].…”

Section: Role Of Magnetic Resonance-mammography Before Breast Conservmentioning

confidence: 99%

Practical consensus recommendations regarding the management of sentinel lymph node issues in early breast cancer

Kabra

Aggarwal

Vardhan³

et al. 2018

South Asian J Cancer

View full text Add to dashboard Cite

Axillary lymph node involvement is a very important poor prognostic factor in the clinical staging and management of breast cancer patients. Traditionally, axillary lymph node dissection (ALND) has been used for determining the status of the axillary lymph nodes. More recently the sentinel lymph node biopsy (SLNB) procedure has gained wider acceptance as the standard of care, having the advantage of being less invasivewhile providing good accuracy. This expert group used data from published literature, practical experience and opinion of a large group of academic oncologists to arrive at these practical consensus recommendations in regards with the use of the two different procedures and other issues in patients with early breast cancer for the benefit of community oncologists.

show abstract